Detalles de la búsqueda
1.
Results from a single arm, single stage phase II trial of trametinib and GSK2141795 in persistent or recurrent cervical cancer.
Gynecol Oncol
; 154(1): 95-101, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31118140
2.
Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC).
Prostate
; 78(12): 889-895, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29707790
3.
A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration-resistant prostate cancer.
Prostate
; 2018 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29882250
4.
Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00.
Breast Cancer Res Treat
; 170(2): 351-360, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29589138
5.
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial.
Breast Cancer Res
; 18(1): 110, 2016 11 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27825388
6.
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.
Breast Cancer Res Treat
; 158(2): 323-31, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27372069
7.
Risk of prostate cancer-specific death in men with baseline metabolic aberrations treated with androgen deprivation therapy for biochemical recurrence.
BJU Int
; 118(6): 919-926, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26805930
8.
Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer.
Cancer
; 121(15): 2603-11, 2015 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25903013
9.
ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.
Breast Cancer Res Treat
; 154(3): 543-55, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26590813
10.
CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
Breast Cancer Res Treat
; 151(2): 373-84, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25935582
11.
Patients with Biopsy Gleason 9 and 10 Prostate Cancer Have Significantly Worse Outcomes Compared to Patients with Gleason 8 Disease.
J Urol
; 194(1): 91-7, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25623747
12.
Elevated insulin-like growth factor binding protein-1 (IGFBP-1) in men with metastatic prostate cancer starting androgen deprivation therapy (ADT) is associated with shorter time to castration resistance and overall survival.
Prostate
; 74(3): 225-34, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24132762
13.
Elevated IL-8, TNF-α, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival.
Prostate
; 74(8): 820-8, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24668612
14.
Craniocaudal retroperitoneal node length as a risk factor for relapse from clinical stage I testicular germ cell tumor.
AJR Am J Roentgenol
; 203(4): W415-20, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25247970
15.
Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study.
Lancet Oncol
; 14(1): 81-7, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23219378
16.
A Patient Portal Intervention to Promote Adolescent and Young Adult Self-Management Skills.
Acad Pediatr
; 23(6): 1252-1258, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36764579
17.
Impact of the COVID-19 Pandemic on Childhood Lead Testing and Blood Lead Levels.
Acad Pediatr
; 2023 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37979935
18.
Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Week 24 Results From IMPAACT 2014.
J Acquir Immune Defic Syndr
; 92(2): 153-161, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36215957
19.
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1-2 trial.
Lancet HIV
; 9(5): e332-e340, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35489377
20.
Bone targeted therapy and skeletal related events in the era of enzalutamide and abiraterone acetate for castration resistant prostate cancer with bone metastases.
Prostate Cancer Prostatic Dis
; 24(2): 341-348, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32884090